Latest news
AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 12:42:53 GMTInnate Pharma advances lacutamab to Phase 3 and appoints CMO - World Business OutlookWorld Business Outlook · Mon, 10 Aug 2026 09:40:28 GMTInnate Pharma to Advance Lacutamab Towards Phase 3 Following Partnership With Sobi and Appoints New Chief Medical Officer - Business WireBusiness Wire · Mon, 10 Aug 2026 06:30:00 GMTPublic hospital in the Negev to enter planning and oversight phase - jpost.comjpost.com · Sun, 09 Aug 2026 14:35:00 GMTTrivarX Appoints Clinical-Stage CEO and Advances Stabl-Im Toward Phase 1 Trial Launch - KalkineKalkine · Tue, 28 Jul 2026 04:03:20 GMT